The bottom line While a balanced diet is the best source of nutrients, this can be difficult to achieve after bariatric surgery or with reduced appetite from GLP-1 therapy
Unlike the supplement industry's usual suspects, which tend to promise everything and deliver little, GHK-Cu has built its reputation the hard way: through peer-reviewed research, clinical trials, and reproducible results across multiple applications
For patients considering GLP-1 therapy, understanding your baseline cardiovascular risk profile and metabolic biomarkers before starting treatment can clarify realistic expectations and help align therapy goals with your health priorities
Some providers explore microdosing GLP-1 for autoimmune conditions , which follows a completely different dosing and timeline protocol than weight management
27% are disease managers who focus on their medical condition and side effects
A study published in the journal Nutrients (Steinert et al., 2018) found that at a dose of 17.1 mmol, oral L-arginine stimulated the release of plasma GLP-1 following a meal in healthy human volunteers
